Cantor Fitzgerald doubled down on its bearish stance toward stocks on Monday, reaffirming its negative outlook with the statement, “we continue to be bearish on equities” in an investor note ...

On Monday, Rivian Automotive Inc (NASDAQ:RIVN), currently valued at approximately $12.7 billion, maintained its Neutral stock rating, as confirmed by analysts at Cantor Fitzgerald. The electric ...

Bradmer Pharmaceuticals Inc. (TSE:GLX – Free Report) – Research analysts at Cantor Fitzgerald cut their FY2025 earnings estimates for shares of Bradmer Pharmaceuticals in a note issued to ...

Cantor Fitzgerald upgraded Tesla (TSLA, Financials) to Overweight from Neutral, citing a buying opportunity following the recent sell-off, the firm announced after a site visit to Tesla's ...

Metsera, Inc. (NASDAQ:MTSR – Free Report) – Equities research analysts at Cantor Fitzgerald reduced their FY2025 earnings per share estimates for Metsera in a report issued on Thursday ...

Cantor Fitzgerald assumed coverage of Aclaris Therapeutics (ACRS) with an Overweight rating. Cantor is bullish on the TSLP and IL-4R bispecific, which looks differentiated, and even early proof-of ...

On Monday, Cantor Fitzgerald reaffirmed its Overweight rating on Tesla stock (NASDAQ:TSLA), the $770 billion market cap electric vehicle manufacturer, emphasizing its strategic focus on domestic ...

Tesla (NASDAQ:TSLA) attracted an upgrade from Cantor Fitzgerald on Wednesday after the firm visited the company's Gigafactory and AI data centers in Austin. The firm moved Tesla (NASDAQ ...

Tuesday - Shares of Microsoft Corporation (NASDAQ:MSFT), the $2.66 trillion tech giant with an impressive 69.41% gross profit margin, are in focus after Cantor Fitzgerald reiterated an Overweight ...

Cantor Fitzgerald biotech analysts slammed the leadership of Health and Human Services Secretary Robert F. Kennedy Jr., calling on the Trump administration to “re-evaluate” his role after a ...

Fintel reports that on March 19, 2025, Cantor Fitzgerald upgraded their outlook for Tesla (SNSE:TSLACL) from Neutral to Overweight. There are 5,232 funds or institutions reporting positions in Tesla.